Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 276

Results For "Clinical"

3374 News Found

Wipro and Pandorum partner to accelerate regenerative medicine with AI
News | March 12, 2022

Wipro and Pandorum partner to accelerate regenerative medicine with AI

Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes


China approves BeiGene’s tislelizumab
Drug Approval | March 12, 2022

China approves BeiGene’s tislelizumab

Tislelizumab is now approved for seven indications in China


BioPharma’s Herceptin biosimilar Phase 3 results positive
Biotech | March 12, 2022

BioPharma’s Herceptin biosimilar Phase 3 results positive

The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile


AbbVie and Gedeon Richter to collaborate on neuropsychiatric diseases
Biotech | March 11, 2022

AbbVie and Gedeon Richter to collaborate on neuropsychiatric diseases

Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products


Daiichi Sankyo commits US $1 million humanitarian aid to Ukraine
Sustainability | March 11, 2022

Daiichi Sankyo commits US $1 million humanitarian aid to Ukraine

The money will be donated to the United Nations Children’s Fund (UNICEF)


Emmes acquires Casimir, its fourth major acquisition
Biotech | March 11, 2022

Emmes acquires Casimir, its fourth major acquisition

Casimir further differentiates Emmes’ industry-leading rare disease research capabilities


First-in-human trial in US for Gan & Lee type 2 diabetes drug
Biotech | March 11, 2022

First-in-human trial in US for Gan & Lee type 2 diabetes drug

The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers


Pfizer initiates Phase2/3 study of Paxlovid in pediatric participants
Biotech | March 10, 2022

Pfizer initiates Phase2/3 study of Paxlovid in pediatric participants

Paxlovid is the first oral therapy specifically designed to combat Covid-19 to be evaluated in a pediatric clinical study


Insilico Medicine and University of Zurich partner to find therapy for Cystinosis
News | March 10, 2022

Insilico Medicine and University of Zurich partner to find therapy for Cystinosis

The Mechanisms of Inherited Kidney Disorders (MIKADO) group at the University of Zurich (UZH) and Insilico Medicine will be working together to identify, rank, and annotate novel drug targets to identify potential therapeutics for cystinosis


Gujarat Biotech policy offers incentives to attract small and large firms
News | March 10, 2022

Gujarat Biotech policy offers incentives to attract small and large firms

The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers